Q4 2024 Earnings Call February 12, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne - ...

Good afternoon, and welcome to the Sensata Technologies’ Fourth Quarter and Full-Year 2024 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event ...

In an interview, Debra Patt, MD, PhD, MBA, FASCO, discusses the priorities of the Community Oncology Alliance as she starts ...

In an extract from The Conversation’s new book on democracy, we chart the origins of the parties that dominate politics today ...

The Stuff+ projections are back with more information than ever to help steer you toward the starting pitchers who can help win your league.

Jignanshu Gor, from Bernstein India, shares insights on retail and restaurant stocks, highlighting an outperform rating on ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Management sits around the conference table, reviewing the most recent quality data regarding expense report rejections. “I ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

By scouring the web rather than just relying on an LLM, ‘deep research’ comes up with far better results than plain old AI bots.

In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...